Nuvectis Pharma, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
August 09, 2023 at 04:15 pm EDT
Nuvectis Pharma, Inc. reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported net loss was USD 5.71 million compared to USD 3.57 million a year ago. Basic loss per share from continuing operations was USD 0.38 compared to USD 0.28 a year ago.
For the six months, net loss was USD 9.76 million compared to USD 6.51 million a year ago. Basic loss per share from continuing operations was USD 0.65 compared to USD 0.59 a year ago.